NKX2-2 and metastatic prostate carcinoma: Male-specific DEGs include MCM7, a DNA replication licensing factor [28]; NKX2-2, an important biomarker for metastatic prostate cancers [38]; and NGFR, the canonical single-pass transmembrane receptor linked to melanoma [39] and squamous cell carcinoma [40].